Interleukin-6 and CAAT/Enhancer Binding Protein β-Deficient Mice Act as Tools to Dissect the IL-6 Signalling Pathway and IL-6 Regulation

This publication has 25 references indexed in Scilit:

• IMPAIRED STAT3 ACTIVATION FOLLOWING LOCALIZED INFLAMMATORY STIMULUS IN IL-6-DEFICIENT MICE
  Cytokine, 1998
• Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice.
  The Journal of Experimental Medicine, 1996
• TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
  Annual Review of Biochemistry, 1995
• Stat3: a STAT Family Member Activated by Tyrosine Phosphorylation in Response to Epidermal Growth Factor and Interleukin-6
  Science, 1994
• Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway
  Cell, 1994
• Impaired immune and acute-phase responses in interleukin-6-deficient mice
  Nature, 1994
• A Common Nuclear Signal Transduction Pathway Activated by Growth Factor and Cytokine Receptors
  Science, 1993
• Single‐step purification and structural characterization of human interleukin‐6 produced in Esherichia coli From a T7 RNA polymerase expression vector
  European Journal of Biochemistry, 1991
• Biological and clinical aspects of interleukin 6
  Immunology Today, 1990
• Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.
  Journal of Clinical Investigation, 1990